453 related articles for article (PubMed ID: 23138014)
1. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Tardif JC; Ponikowski P; Kahan T;
Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
[TBL] [Abstract][Full Text] [Related]
3. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
Perings S; Stöckl G; Kelm M;
Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.
Li Y; Jing L; Li Y; Jiang J; Wang Z; Wei J; Li X; Wang L; Xia H; Li T; Liu S; Xing B; Yang Z; Lu Q; Jiang R; Xie P; Shou X; Wang X; Jia Y
Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1183-91. PubMed ID: 24757084
[TBL] [Abstract][Full Text] [Related]
6. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
7. Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.
Werdan K; Ebelt H; Nuding S; Höpfner F; Hack G; Müller-Werdan U
Clin Res Cardiol; 2012 May; 101(5):365-73. PubMed ID: 22231643
[TBL] [Abstract][Full Text] [Related]
8. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study).
Glezer M; Vasyuk Y; Karpov Y
Adv Ther; 2018 Mar; 35(3):341-352. PubMed ID: 29508153
[TBL] [Abstract][Full Text] [Related]
10. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Borer JS; Fox K; Jaillon P; Lerebours G;
Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
[TBL] [Abstract][Full Text] [Related]
11. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study.
Vitale C; Spoletini I; Malorni W; Perrone-Filardi P; Volterrani M; Rosano GM
Int J Cardiol; 2013 Sep; 168(2):1078-81. PubMed ID: 23200272
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial.
Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U;
Cardiology; 2016; 133(2):83-90. PubMed ID: 26501486
[TBL] [Abstract][Full Text] [Related]
14. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Tardif JC; Ponikowski P; Kahan T;
Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
17. Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device.
Jedlickova L; Merkovska L; Jackova L; Janicko M; Fedacko J; Novakova B; Chmelarova A; Majernik J; Pella D
Adv Ther; 2015 Oct; 32(10):962-70. PubMed ID: 26525390
[TBL] [Abstract][Full Text] [Related]
18. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
Nedoshivin A; Petrova PTS; Karpov Y
Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
[TBL] [Abstract][Full Text] [Related]
20. Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
Riccioni G; Prencipe G; Benvenuto A; Masciocco L; Ventra S; Rizzo U; Russi C; Speziale G
Pharmacology; 2013; 91(1-2):35-8. PubMed ID: 23146926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]